Microenvironment improvement protocol for the sensitive spectrofluorimetric determination of an hepatitis C virus antiviral (Simeprevir): application to human plasma.
Sayed M DerayeaMohamed A El HamdSayed AliEbtihal SamirPublished in: Luminescence : the journal of biological and chemical luminescence (2019)
Simeprevir (SPV) is a powerful antihepatitis C virus agent that was newly introduced into the pharmaceutical market. We here established and validated an easy, simple, and sensitive spectrofluorimetric method for its estimation at λem 427 nm (λex 337 nm). The suggested procedure was based on two times enhancement in the original emission of SPV through modifying its microenvironment in buffered aqueous solution by adding Triton X-100. The relationship between the concentration of SPV and the observed fluorescence intensity was linear in the range 0.06-1.0 μg ml-1 with a correlation coefficient of 0.9997. The limits of detection and quantitation were 21 and 64 ng ml-1 , respectively. The present method was effectively applied to quantify SPV content in pharmaceutical tablets and human plasma spiked with the drug with no interference from tablet excipients or plasma components.
Keyphrases
- hepatitis c virus
- aqueous solution
- stem cells
- photodynamic therapy
- human immunodeficiency virus
- ms ms
- solid phase extraction
- randomized controlled trial
- mass spectrometry
- high intensity
- health insurance
- emergency department
- high performance liquid chromatography
- liquid chromatography
- minimally invasive
- diffusion weighted imaging
- magnetic resonance
- tandem mass spectrometry
- real time pcr
- high resolution
- solid state
- hiv infected